Guardian Capital Group Opens the Market
Guardian Capital Group Opens the Market
PR Newswire
TORONTO, July 11, 2024
TORONTO, July 11, 2024 /PRNewswire/ - George Mavroudis, CEO and President, Guardian Capital Group (TSX: GCG) and his team joined Graham MacKenzie, Managing Director, Exchange Traded Products, Toronto Stock Exchange, to celebrate the Company's 55-year listing anniversary and open the market.
Guardian Capital Group Limited (Guardian) is a global investment management company servicing institutional, retail and private clients through its subsidiaries. As at March 31, 2024, Guardian had C$61.3 billion of total client assets while managing a proprietary investment portfolio with a fair market value of C$1.25 billion. Founded in 1962, Guardian's reputation for steady growth, long-term relationships and its core values of authenticity, integrity, stability and trustworthiness have been key to its success over six decades. Its Common and Class A shares are listed on the Toronto Stock Exchange as GCG and GCG.A, respectively. To learn more about Guardian, visit www.guardiancapital.com.
CNW sponsored announcement. To learn more visit www.newswire.ca.
View original content to download multimedia:https://www.prnewswire.com/news-releases/guardian-capital-group-opens-the-market-302195096.html
SOURCE Toronto Stock Exchange
-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks